TNFSF11 and rheumatoid arthritis: Although CD11bdull/−Ly6Chigh monocytes increase in response to pathological conditions, including rheumatoid arthritis,21 mice treated with anti-RANKL antibody had a comparable number of these cells as the control mice (Fig. S4).